• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.11%

    More On DIVISLAB.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Divi's Laboratories Limited (DIVISLAB.BO)

    -BSE
    1,701.65 Up 27.20(1.62%) 5:27AM EST
    Add to Portfolio
    Prev Close:1,674.45
    Open:1,699.75
    Bid:1,701.65
    Ask:1,715.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1,664.40 - 1,712.60
    52wk Range:1,165.00 - 1,881.90
    Volume:5,796
    Avg Vol (3m):13,869
    Market Cap:225.87B
    P/E (ttm):29.21
    EPS (ttm):58.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Headlines

    • No Headlines available for DIVISLAB.BO at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback